AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE
AgNovos Bioscience announces that more than 150 patients have been enrolled in the RESTORE randomized, controlled trial of AGN1 LOEP.
News & Events
Keep up to date on AgNovos events and related news
Archive - 2023
Corporate Rebranding Announcement
AgNovos Healthcare Announces Corporate Renaming as AgNovos Bioscience